• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FREE PSA IMMUNOASSAY V3; FREE PROSTATE-SPECIFIC ANTIGEN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FREE PSA IMMUNOASSAY V3; FREE PROSTATE-SPECIFIC ANTIGEN Back to Search Results
Catalog Number 08828601160
Device Problem Incorrect Measurement (1383)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/14/2022
Event Type  malfunction  
Manufacturer Narrative
The patient's sample was requested but not available for an investigation.The investigation reviewed the qc results and no abnormalities were found.The investigation reviewed the system's alarm trace and found an abnormal sample aspiration alarm.Per product labeling, "the elecsys free psa immunoassay should be used only with the elecsys total psa immunoassay to calculate the ratio (% fpsa) of free psa (fpsa) to total psa (tpsa).Use of another manufacturer¿s total psa assay may result in an inappropriate population of patients selected for fpsa testing; and significantly different fpsa to tpsa ratios, cutoffs and prostate cancer probabilities than represented in the "expected values" section of this method sheet.Ratios must be calculated using tpsa and fpsa results both obtained on the same elecsys platform, i.E.Both obtained on either the cobas e 411, cobas e 601 or cobas e 602 immunoassay analyzer.The measured fpsa value of a patient¿s sample can vary depending on the testing procedure used.The laboratory finding must therefore always contain a statement on the fpsa assay method used.Free psa values determined on patient samples by differing testing procedures cannot be directly compared with one another and could be the cause of erroneous medical interpretations." based on the provided information, the investigation did not identify a product problem.The cause of the event could not be determined.
 
Event Description
The initial reporter received questionable elecsys total psa and elecsys free psa immunoassay results for one patient tested on a cobas 6000 e 601 module serial number (b)(4).On (b)(6) 2022, the elecsys psa results were not reported outside the laboratory.The customer performed repeat testing with the sample on the same e 601 module.On (b)(6) 2022, a new sample was collected and tested on the e 601 module.On (b)(6) 2022, the customer sent the sample to a different laboratory and the sample was tested with chemiluminescence methodology.On (b)(6) 2022, the patient's initial results on the e 601 module were total psa 0.80 ng/ml and free psa 1.33 ng/ml.The patient's repeat results on the e 601 module were total psa 0.81 ng/ml and free psa 1.39 ng/ml.On (b)(6) 2022, the patient's new sample was tested on the e 601 module and the results were total psa 0.084 ng/ml and free psa 1.30 ng/ml.On (b)(6) 2022, the patient's results with the chemiluminescence methodology were total psa 0.93 ng/ml and free psa 0.02 ng/ml.The elecsys total psa reagent lot number was 556098 with an expiration date of 30-nov-2022.The elecsys free psa reagent lot number was 546160 with an expiration date of 30-sep-2022.This medwatch is for free psa.Refer to the medwatch with patient identifier (b)(6) for the total psa assay.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FREE PSA IMMUNOASSAY V3
Type of Device
FREE PROSTATE-SPECIFIC ANTIGEN
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key15006114
MDR Text Key304607240
Report Number1823260-2022-02082
Device Sequence Number1
Product Code LTJ
UDI-Device Identifier07613336166673
UDI-Public07613336166673
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P000027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 07/13/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2022
Device Catalogue Number08828601160
Device Lot Number546160
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/21/2022
Initial Date FDA Received07/13/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age75 YR
-
-